Skip to main content
Premium Trial:

Request an Annual Quote

DNAnexus Developing NGS Workflows with Geisinger, UCSF

NEW YORK (GenomeWeb News) – DNAnexus today announced deals with the Geisinger Health System and the University of California, San Francisco to develop clinically relevant workflows.

The workflows will provide new information for the use of DNA sequencing in clinical applications, the Mountain View, Calif.-based data management and analysis firm said.

As part of the deals, laboratories at Geisinger and UCSF will leverage DNAnexus' cloud-based software platform to upload, store, and analyze sequencing data. Additionally, in conjunction with the Geisinger Clinical Program for Whole Genome Sequencing, Geisinger will be able to access DNAnexus' genomic data management capabilities, such as visualization, analysis, and storage.

Geisinger will provide "strategic counsel" for the use of next-generation sequencing data for clinical applications and will extend DNAnexus' capabilities to support use of the data.

Financial terms of the agreements were not disclosed.

DNAnexus was founded in 2009 and provides solutions to sequencing centers and researchers working with next-gen sequencing data. In the fall, it announced it had raised $15 million and would collaborate with Google to support hosting of the public Sequence Read Archive database.

"By partnering with highly respected healthcare and research institutions like Geisinger and UCSF, we will be able to learn from clinical experts and build an even more innovative solution that will enable research, medical, and biotech communities to unlock the full potential of DNA data," Andreas Sundquist, co-founder and CEO of DNAnexus, said in a statement.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.